• GAPNA 2020 National President Deborah Dunn, EdD, MSN, GNP-BC, ACNS-BC, GS-C interviews Dr. Ron Billano Ordona, DNP, FNP-BC about providing home-based primary care during COVID 19.

    "Facing Forward: Providing Home-based Primary Care during COVID 19"

    View the Video

  • GAPNA 40th AnniversaryGAPNA’s anniversary theme “Preserve the Past, Enhance the Present, and Secure the Future,” reflects our shared vision for gerontological advanced practice nursing.


    Learn How You Can Help

  • GAPNA Exchange


    GAPNA Exchange is a private, secure community for members to share ideas, ask questions, lend expertise, and network with peers.

    It features both an Open Forum discussion area along with smaller, segmented communities.

    Interact with GAPNA members wherever and whenever!

    Go to GAPNA Exchange

  • CoronaCoronavirus (COVID-19) Resources

    In an effort to support our members with the most updated information on COVID-19 we developed this resource page to easily access current CDC information and other resources to assist you professionally and personally.

    We will continue to update this page with more information as it becomes available and welcome your input as we navigate through this situation. As health care professionals it is our job to educate our patients and families on prevention and the what to do if someone is symptomatic.

    View resources


Drug-Eluting Stents Appear Safe for Older Patients with Chronic Kidney Disease

Patients with chronic kidney disease (CKD) make up an increasing percentage of the population undergoing percutaneous coronary intervention (PCI).

A new study suggests most older patients with varying severity of CKD benefit from drug-eluting stents (DES) placed during PCI.

Either a bare-metal stent (BMS) or DES may be placed to keep an artery open during PCI.

The DES has emerged as the stent of choice in patients with CKD in response to the high restenosis (recurrence of blockage) rates of 13%-35% seen with BMS.

However, more than 50% of DESs are being placed in patient subgroups that were not included in the large randomized controlled trials.

Concerns have arisen that increased rates of late stent thrombosis in older patients with CKD after implantation with a DES may offset any potential benefit of fewer recurrent blockages.

The new study allays some of those concerns. It found most subgroups of older patients with CKD who received a DES had significantly lower mortality rates throughout 30 months of followup than the patients who received a BMS. Also, the benefits of a DES with regard to myocardial infarction, revascularization, and major bleeding were present in most CKD subgroups.

For more info, see Tsai et al. (2011). Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease. Journal of the American College of Cardiology, 58(180), 1859-1869.

Related Topic 1: 

GAPNA Newsletter Issue: